OtherShort Communication
Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase
Charles W Locuson, Brian T Ethell, Michael Voice, David Lee and Kenneth L Feenstra
Drug Metabolism and Disposition December 12, 2008, DOI: https://doi.org/10.1124/dmd.108.025312
Charles W Locuson
Brian T Ethell
Michael Voice
David Lee
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherShort Communication
Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase
Charles W Locuson, Brian T Ethell, Michael Voice, David Lee and Kenneth L Feenstra
Drug Metabolism and Disposition December 12, 2008, DOI: https://doi.org/10.1124/dmd.108.025312
OtherShort Communication
Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase
Charles W Locuson, Brian T Ethell, Michael Voice, David Lee and Kenneth L Feenstra
Drug Metabolism and Disposition December 12, 2008, DOI: https://doi.org/10.1124/dmd.108.025312
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement